• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Septin-14 (41531)

ACP16515

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP16515 Target NameSEPT14
Target SynonymsFLJ44060; SEP14_HUMAN; SEPT 14; Sept14; Septin 14; Septin-14; Septin14FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-432
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ6ZU15
Background Information
  • Uniprot Id

    Q6ZU15

  • Target Species

    Human

  • Target Name

    SEPT14

  • Target Full Name

    Septin-14

  • Target Function

    Filament-forming cytoskeletal GTPase (Probable). Involved in the migration of cortical neurons and the formation of neuron leading processes during embryonic development. Plays a role in sperm head formation during spermiogenesis, potentially via facilitating localization of ACTN4 to cell filaments.

  • Target Subcellular Location

    Cytoplasm. Cytoplasm, cytoskeleton. Cell projection, axon. Cell projection, dendrite. Perikaryon. Cytoplasm, perinuclear region. Cytoplasmic vesicle, secretory vesicle, acrosome.

  • Target Protein Families

    TRAFAC class TrmE-Era-EngA-EngB-Septin-like GTPase superfamily, Septin GTPase family

  • Target Tissue Specificity

    Testis-specific (at protein level).

  • Target Synonyms

    FLJ44060; SEP14_HUMAN; SEPT 14; Sept14; Septin 14; Septin-14; Septin14

Inquire Recombinant Human Septin-14 (41531) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification